Antisense inhibition of focal adhesion kinase expression
US6133031A · kind A · utility
38Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1999 |
| Grant date | Oct 17, 2000 |
| Priority date | — |
| Expiry date | Aug 19, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for inhibiting FAK mediated signaling. The compositions comprise antisense compounds targeted to nucleic acids encoding FAK. Methods of using these antisense compounds for inhibition of FAK expression and for treatment of diseases, particularly cancers, associated with overexpression or constitutive activation of FAK are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.